NO178663C - Framgangsmåte for framstilling av et terapeutisk aktivt polypeptid - Google Patents

Framgangsmåte for framstilling av et terapeutisk aktivt polypeptid

Info

Publication number
NO178663C
NO178663C NO940078A NO940078A NO178663C NO 178663 C NO178663 C NO 178663C NO 940078 A NO940078 A NO 940078A NO 940078 A NO940078 A NO 940078A NO 178663 C NO178663 C NO 178663C
Authority
NO
Norway
Prior art keywords
preparing
same
therapeutically active
active polypeptide
lipopolysaccharide
Prior art date
Application number
NO940078A
Other languages
English (en)
Other versions
NO940078D0 (no
NO940078L (no
NO178663B (no
Inventor
Takanori Nakamura
Sadaaki Iwanaga
Motonori Ohno
Kyosuke Miyazaki
Original Assignee
Seikagaku Kogyo Kk Seikagaku C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO940078L publication Critical patent/NO940078L/no
Application filed by Seikagaku Kogyo Kk Seikagaku C filed Critical Seikagaku Kogyo Kk Seikagaku C
Publication of NO940078D0 publication Critical patent/NO940078D0/no
Publication of NO178663B publication Critical patent/NO178663B/no
Publication of NO178663C publication Critical patent/NO178663C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
NO940078A 1987-08-21 1994-01-10 Framgangsmåte for framstilling av et terapeutisk aktivt polypeptid NO178663C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP20625887 1987-08-21
PCT/JP1988/000823 WO1989001492A1 (en) 1987-08-21 1988-08-19 Novel polypeptide and method for preparing the same
NO891572A NO175372C (no) 1987-08-21 1989-04-18 Analogifremgangsmåte for framstilling av et terapeutisk aktivt polypeptid

Publications (4)

Publication Number Publication Date
NO940078L NO940078L (no) 1989-05-09
NO940078D0 NO940078D0 (no) 1994-01-10
NO178663B NO178663B (no) 1996-01-29
NO178663C true NO178663C (no) 1996-05-08

Family

ID=16520353

Family Applications (2)

Application Number Title Priority Date Filing Date
NO891572A NO175372C (no) 1987-08-21 1989-04-18 Analogifremgangsmåte for framstilling av et terapeutisk aktivt polypeptid
NO940078A NO178663C (no) 1987-08-21 1994-01-10 Framgangsmåte for framstilling av et terapeutisk aktivt polypeptid

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO891572A NO175372C (no) 1987-08-21 1989-04-18 Analogifremgangsmåte for framstilling av et terapeutisk aktivt polypeptid

Country Status (13)

Country Link
US (2) US5068314A (no)
EP (1) EP0343248B1 (no)
JP (1) JP2710653B2 (no)
KR (1) KR970001811B1 (no)
CN (1) CN1031193C (no)
AT (1) ATE88480T1 (no)
AU (1) AU642089B2 (no)
CA (2) CA1337781C (no)
DE (1) DE3880481T2 (no)
DK (1) DK193589A (no)
FI (1) FI92708C (no)
NO (2) NO175372C (no)
WO (1) WO1989001492A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337781C (en) * 1987-08-21 1995-12-19 Takanori Nakamura Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation
US5594113A (en) * 1988-06-23 1997-01-14 Associates Of Cape Cod, Inc. Endotoxin binding and neutralizing protein and uses thereof
RO109653B1 (ro) * 1990-09-11 1995-04-28 Seikagaku Kogyo Co Ltd Polipeptide
DE69211973T2 (de) * 1991-12-25 1996-12-19 Maruha Corp Reagenzien und Verfahren zur Bestimmung von Beta-Glucanen
JP3361830B2 (ja) * 1992-03-30 2003-01-07 生化学工業株式会社 抗菌性組成物及びそれを有効成分とする薬剤
DE69219590T2 (de) * 1992-05-30 1997-11-27 Marko Duvnjak BPC-Peptide, deren Herstellung und Verwendung
JP3402476B2 (ja) * 1992-08-24 2003-05-06 生化学工業株式会社 リポ多糖結合性タンパク質及びその製造法
CA2112776C (en) * 1993-01-21 2002-11-12 Masakazu Tsuchiya Process for inhibiting activity of endotoxin
EP0664814A1 (en) 1993-08-18 1995-08-02 MorphoSys AG Lipopolysaccharide-binding and neutralizing peptides
WO1995010534A1 (en) * 1993-10-14 1995-04-20 Seikagaku Corporation Polypeptide and anti-hiv agent prepared therefrom
KR100257310B1 (ko) * 1996-12-21 2000-05-15 정몽규 트렁크 리드 개폐장치
US6011066A (en) * 1998-02-02 2000-01-04 Veterans General Hospital-Taipei Method for treating septic shock
CN100389140C (zh) * 2006-05-12 2008-05-21 北京理工大学 由聚肽-b-聚四氢呋喃-b-聚肽三嵌段共聚物制备纳米及微米级自组装体的方法
US8715685B2 (en) * 2009-07-14 2014-05-06 Lucia Irene Gonzalez Stereoisomer peptides and their polymer conjugates for HIV disease
CN108623659B (zh) * 2018-03-17 2021-09-14 中国海洋大学 一种氨基酸全部选用d型氨基酸的抗菌肽合成方法
WO2021183061A1 (en) * 2020-03-13 2021-09-16 Vet Products Research And Innovation Center Company Limited Antimicrobial peptides for inhibition of pathogenic microorganisms in digestive and respiratory tracts in animal

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663435A (en) * 1982-12-06 1987-05-05 Merck & Co., Inc. Bridged cyclic hexapeptide somatostatin analogs
CA1337781C (en) * 1987-08-21 1995-12-19 Takanori Nakamura Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation

Also Published As

Publication number Publication date
WO1989001492A1 (en) 1989-02-23
EP0343248A1 (en) 1989-11-29
CN1031379A (zh) 1989-03-01
EP0343248B1 (en) 1993-04-21
NO940078D0 (no) 1994-01-10
DE3880481D1 (de) 1993-05-27
JPH02500194A (ja) 1990-01-25
DK193589D0 (da) 1989-04-20
AU642089B2 (en) 1993-10-07
CA1337781C (en) 1995-12-19
AU620345B2 (en) 1992-02-20
ATE88480T1 (de) 1993-05-15
DE3880481T2 (de) 1993-09-09
DK193589A (da) 1989-06-16
NO940078L (no) 1989-05-09
NO178663B (no) 1996-01-29
NO891572D0 (no) 1989-04-18
KR970001811B1 (ko) 1997-02-15
AU2311388A (en) 1989-03-09
US5416194A (en) 1995-05-16
FI92708B (fi) 1994-09-15
FI891873A (fi) 1989-04-19
FI891873A0 (fi) 1989-04-19
US5068314A (en) 1991-11-26
NO175372B (no) 1994-06-27
NO891572L (no) 1989-05-09
AU1702892A (en) 1992-07-16
CN1031193C (zh) 1996-03-06
KR890701624A (ko) 1989-12-21
FI92708C (fi) 1994-12-27
CA1337782C (en) 1995-12-19
NO175372C (no) 1994-10-05
JP2710653B2 (ja) 1998-02-10

Similar Documents

Publication Publication Date Title
NO178663C (no) Framgangsmåte for framstilling av et terapeutisk aktivt polypeptid
EP0341915A3 (en) Anti-aggregatory peptides
DE69128664D1 (de) CNP-Gen und Vorläuferprotein aus Schwein
AU1377092A (en) Peptides for treatment
Kuromizu et al. Reexamination of the primary structure of an antitumor protein, neocarzinostatin
WO2001027136A3 (fr) Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire
AU671989B2 (en) Treatment of tropical spastic paresis with peptide T
AU1599892A (en) Novel polypeptides with affinity to lipopolysaccharides and their uses
KR890003409A (ko) 점막 투여시 흡수 촉진제로서의 시클릭 펩티드
AU585167B2 (en) Novel substrate peptides
RU94024392A (ru) Минерально-аминокислотный концентрат
RU94046096A (ru) Линейные или циклические пептиды, их применение, способы лечения и конъюгаты пептидов
DE69813232D1 (de) Wespe pompilid neuropeptide
UA28084C2 (uk) Протипухлинний засіб, виділений з слизової кишечника, спосіб його виділення
RU97114945A (ru) Белки против ожирения

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN FEBRUARY 2003